BDKRB2 and neoplasm: B2R partakes in tumor angiogenesis [26] and in pathological neovascularization in oxygen-induced retinopathy, where B2R blockade reduced retinal neovascularization and the expression of proangiogenic and pro-inflammatory cytokines [25].